News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Beech Tree Labs, Inc.’ Data Points Toward Potential TB Treatment
September 13, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PROVIDENCE, R.I.--(BUSINESS WIRE)--Beech Tree Labs, Inc. announced today publication of data providing evidence that its novel product candidate addressing scarring and wound healing showed efficacy in a Mycobacterium tuberculosis (TB) animal model.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
MORE ON THIS TOPIC
Immunology and inflammation
Priovant Plots Path to Phase 3 as Brepocitinib Clears Mid-Stage Skin Disease Study
February 6, 2026
·
2 min read
·
Tristan Manalac
Obesity
Obesity Space Abuzz With Oral, Amylin Assets as Momentum Rides Into 2026
February 6, 2026
·
4 min read
·
Mark Zipkin
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
·
1 min read
·
Jennifer Smith-Parker
Duchenne muscular dystrophy
Sarepta Saga Has ‘Gone on Too Long’ as Competitors Catch Up
February 5, 2026
·
5 min read
·
Dan Samorodnitsky